Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al

Affiliations

• ¹ Institute of Molecular and Cellular Biology, Agency for Science, Technology and Research, Singapore, Singapore.
• ² Institute for Transfusion Medicine, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
• ³ Department of Medicine, University of Vermont, Burlington, Vermont, USA.
• ⁴ Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ⁵ Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ⁶ GMP Unit, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), University Hospital, Salzburg, Austria.
• ⁷ Department of Transfusion Medicine, Salzburger Landeskliniken GesmbH (SALK), Paracelsus Medical University (PMU), University Hospital, Salzburg, Austria.
• ⁸ Research and Transfer Center for Extracellular Vesicle Theralytic Technologies in Salzburg (EV-TT), Salzburg, Austria.